LESSON 3: SUPPLEMENTAL READING Flashcards

(53 cards)

1
Q

(?) is the study of how resources are allocated within the health sector to improve population health outcomes efficiently and equitably.

A

PUBLIC HEALTH ECONOMICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

(?) helps governments and decision-makers use economic principles to improve health systems. It ensures limited resources are used wisely, interventions are cost-effective, and populations, especially vulnerable groups, are treated equitably.

A

PUBLIC HEALTH ECONOMICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Health resources (e.g., funding, medical personnel, hospital beds) are limited, so they must be allocated efficiently to maximize health benefits.

A

RESOURCE ALLOCATION AND SCARCITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Evaluates the costs and health outcomes of different interventions to determine which provides the best value for money.

A

COST-EFFECTIVENESS ANALYSIS (CEA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Compares the costs of an intervention to the monetary value of its benefits, helping policymakers decide whether an intervention is worth the investment.

A

COST-BENEFIT ANALYSIS (CBA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Balances economic efficiency (maximizing health benefits per dollar spent) with equity (ensuring fair access to health services, especially for vulnerable populations).

A

HEALTH EQUITY & EFFICIENCY TRADE-OFFS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Recognizes that healthcare markets do not always function efficiently due to issues like information asymmetry, externalities (e.g., vaccination benefits beyond the individual), and monopolies in pharmaceutical industries.

A

MARKET FAILURES IN HEALTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Examines how public health programs are funded (e.g., taxation, insurance, donor funding) and ensures long-term financial sustainability.

A

FINANCING & SUSTAINABILITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Studies how psychological and social factors influence individuals’ health-related behaviors and economic choices.

A

BEHAVIORAL ECONOMICS AND HEALTH DECISIONS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Assesses how diseases affect economic productivity, labor markets, and national economic growth.

A

BURDEN OF DISEASE & ECONOMIC IMPACT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Resources like money, health workers, equipment, and medicine are finite. Decisions must be made on how to distribute them across competing health needs.

A

RESOURCE ALLOCATION AND SCARCITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Efficient resource allocation maximizes health outcomes but often requires (?) that can be politically and socially sensitive.

A

TRADE-OFFS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A method to compare interventions based on their costs and health gains, usually expressed in cost per QALY (Quality-Adjusted Life Year) or DALY (Disability-Adjusted Life Year).

A

COST-EFFECTIVENESS ANALYSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Distributing mosquito nets might cost $10 per DALY averted, while building new hospitals might cost $500 per DALY averted.

A

COST-EFFECTIVENESS ANALYSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Helps prioritize interventions that offer the most health benefit per dollar spent.

A

COST-EFFECTIVENESS ANALYSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Enables data-driven decision-making, especially when budgets are tight.

A

COST-EFFECTIVENESS ANALYSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Converts both costs and benefits into monetary terms to determine if the benefits of an intervention outweigh the costs.

A

COST-BENEFIT ANALYSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

A measles vaccine campaign costing $20 million might save $100 million in hospital admissions, lost wages, and funeral costs.

A

COST-BENEFIT ANALYSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Useful in justifying public investment in prevention and long-term health gains.

A

COST-BENEFIT ANALYSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Supports transparent decisions, especially when competing for government or donor funds.

A

COST-BENEFIT ANALYSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Public health must balance equity (fair access) and efficiency (maximum benefit for cost). Sometimes, reaching the poorest costs more but is critical for fairness.

A

HEALTH EQUITY & EFFICIENCY TRADE-OFFS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Health programs should aim to reduce health disparities while maintaining efficient spending.

A

HEALTH EQUITY & EFFICIENCY TRADE-OFFS

23
Q

Policies should be informed by both ethics and economics, possibly using tools like equity weighting.

A

HEALTH EQUITY & EFFICIENCY TRADE-OFFS

24
Q

Health markets often do not function efficiently

A

MARKET FAILURES IN HEALTH

25
Vaccines protecting others
EXTERNALITIES
26
One company holding a patent for a drug
MONOPOLIES
27
Patients don’t have full knowledge
INFORMATION ASSYMETRY
28
Antibiotics sold without prescription can cause resistance, harming the whole population.
MARKET FAILURES IN HEALTH
29
Refers to how health programs are funded and how governments can ensure they are financially sustainable long-term.
HEALTH FINANCING AND SUSTAINABILITY
30
Funded through general taxation (e.g., UK NHS)
TAX-BASED SYSTEMS
31
Employer-employee contributions
SOCIAL HEALTH INSURANCE
32
Recognizes that people often don’t act economically rational, especially regarding health.
BEHAVIORAL ECONOMICS AND HEALTH DECISIONS
33
People may delay vaccinations despite knowing their benefits due to fear, forgetfulness, or peer influence.
BEHAVIORAL ECONOMICS AND HEALTH DECISIONS
34
Uses “nudges” like reminders, rewards, or making healthy choices the default.
BEHAVIORAL ECONOMICS AND HEALTH DECISIONS
35
Improves public compliance and outcomes without coercion or high costs.
BEHAVIORAL ECONOMICS AND HEALTH DECISIONS
36
Health and the economy are deeply linked. Disease reduces productivity, household income, and increases healthcare spending.
BURDEN OF DISEASE AND ECONOMIC IMPACT
37
HIV/AIDS in sub-Saharan Africa reduces workforce capacity and raises healthcare costs, affecting GDP.
BURDEN OF DISEASE AND ECONOMIC IMPACT
38
Indicators used in "Burden of Disease and Economic Impact" (3)
(1) PRODUCTIVITY LOSS (2) HEALTH SYSTEM STRAIN (3) LONG-TERM FISCAL IMPACT
39
Investing in prevention improves both health and economic performance.
BURDEN OF DISEASE AND ECONOMIC IMPACT
40
Ensures universal access but may face budget constraints.
TAX-BASED SYSTEMS
41
Spreads risk but requires strong government oversight.
SOCIAL HEALTH INSURANCE
42
Individual or employer-based insurance plans; Increases choice but may exclude low-income populations.
PRIVATE HEALTH INSURANCE
43
Direct payments for healthcare services; Common in low-income countries but can lead to financial hardship.
OUT-OF-POCKET PAYMENTS
44
(?) is a method of incorporating positive time preference (higher value given to costs and benefits that occur now, compared to those occurring in the future) into the evaluation when the costs and benefits do not occur at the same time period.
DISCOUNTING
45
(?) in health care is a method used to evaluate the relative costs and health outcomes of different interventions to determine which provides the best value for resources spent.
COST-EFFECTIVENESS ANALYSIS
46
CEA is measured through?
(1) QUALITY ADJUSTED LIFE YEARS (2) DISABILITY ADJUSTED LIFE YEARS
47
It is a form of economic evaluation in which health benefits are usually measured in preference-based non-monetary units such as Quality Adjusted Life Years (QALYs) or Disability Adjusted Life Years (DALYs)
COST-UTILITY ANALYSIS
48
QALY FORMULA
LENGHT OF LIFE X QUALITY OF LIFE
49
DALY FORMULA
YEARS LIVED WITH DISABILITY + YEARS OF LIFE LOST
50
Places monetary values on both costs and outcomes. It aims to answer the question is the benefit worth the cost in monetary forms
COST-BENEFIT ANALYSIS
51
It struggles to value intangible outcomes, which are yet to be quantified e.g. happiness, relief from pain.
COST-BENEFIT ANALYSIS
52
Collects, categorizes and lists the cost components of a chosen intervention. This type of analysis lists the components of an intervention in a disaggregated format, without making judgements of their relative importance.
COST-CONSEQUENCE ANALYSIS
53
It has no weighting system to appraise the results. Costs and consequences are presented disaggregated, requiring the decision makers themselves to devise a system to appraise the results
COST-CONSEQUENCE ANALYSIS